Trial Profile
Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease; Juvenile rheumatoid arthritis; Rheumatoid arthritis
- Focus Adverse reactions
- 01 Apr 2021 Status changed from active, no longer recruiting to completed.
- 07 Oct 2019 Planned End Date changed from 1 Apr 2017 to 1 Dec 2019.
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management